CCL2 and metabolic dysfunction-associated steatotic liver disease: 3.5. Ob-NAFLD Upregulates the Gene Expression of Pro-Inflammatory Markers TNF-α, MCP-1, and CXCR2 in the Kidney, While Metformin Treatment Specifically Reduces TNF-α Expression